Quick Summary:
In today's rapidly evolving healthcare landscape, the global Carrier Screening market is taking quantum leaps forward. With expectations to grow from US$2.4 Billion in 2022 to a remarkable US$7.8 Billion by 2030, understanding the dynamics at play in this field could be instrumental to strategic decision-making. Naturally, this journey begins with a robust understanding of the industry landscape, trends, and key players.
The report described in this document offers a comprehensive analysis of the market, with a particular focus on Molecular Screening Test and Biochemical Screening Test segments. It also paints a broad geographical picture, interrogating the market's growth in heavyweight economies such as the US and China, as well as prospective regions including Japan, Canada, and Europe. Featured competitors such as 23andMe, Inc., Abbott Laboratories, and Illumina, Inc., are analyzed in depth; offering the insights you need to stay ahead of the curve.
Global Carrier Screening Market to Reach $7.8 Billion by 2030
The global market for Carrier Screening estimated at US$2.4 Billion in the year 2022, is projected to reach a revised size of US$7.8 Billion by 2030, growing at a CAGR of 15.8% over the analysis period 2022-2030. Molecular Screening Test, one of the segments analyzed in the report, is projected to record 17.6% CAGR and reach US$5.5 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Biochemical Screening Test segment is readjusted to a revised 12.3% CAGR for the next 8-year period.
The U.S. Market is Estimated at $656.9 Million, While China is Forecast to Grow at 21.5% CAGR
The Carrier Screening market in the U.S. is estimated at US$656.9 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$1.9 Billion by the year 2030 trailing a CAGR of 21.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.4% and 13.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 12.5% CAGR.Select Competitors (Total 42 Featured) -
- 23andMe, Inc.
- Abbott Laboratories
- AutoGenomics, Inc.
- F. Hoffmann-La Roche AG
- Illumina, Inc.
- Luminex Corporation
- Myriad Genetics, Inc.
- Sequenom, Inc.
- Thermo Fisher Scientific, Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
What is the estimated value of the Global Market for Carrier Screening?
What is the growth rate of the Global Market for Carrier Screening?
What is the forecasted size of the Global Market for Carrier Screening?
Who are the key companies in the Global Market for Carrier Screening?
| Report Attribute | Details |
|---|---|
| No. of Pages | 173 |
| Published | December 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 2.4 Billion |
| Forecasted Market Value ( USD | $ 7.8 Billion |
| Compound Annual Growth Rate | 15.9% |
| Regions Covered | Global |
Table of Contents
Companies Mentioned
A selection of companies mentioned in this report includes:
- 23andMe, Inc.
- Abbott Laboratories
- AutoGenomics, Inc.
- F. Hoffmann-La Roche AG
- Illumina, Inc.
- Luminex Corporation
- Myriad Genetics, Inc.
- Sequenom, Inc.
- Thermo Fisher Scientific, Inc.
